Subscribe for notification
Tech

Android VP Dave Burke Steps Down to Explore AI/bio Roles

After 14 years, Android Engineering VP Dave Burke steps down to pursue AI/bio projects within Alphabet, marking a new chapter in his career

Burke was involved in several significant initiatives, including the development of Chrome for mobile phones, the launch of Android TV, the construction of Nexus and Pixel phones, and the leadership of efforts to construct and distribute developer tools.

This occurred during a period in which Google had been restructuring its executive team amid redundancies this year.

The corporation terminated over one thousand employees in January, including most of its augmented reality hardware team. James Park and Eric Friedman, co-founders of Fitbit, resigned from their positions at the company.

In April, Google consolidated its hardware and Android teams to incorporate artificial intelligence into its products.

Hiroshi Lockheimer, previously responsible for Android, Chrome, and ChromeOS, began seeking alternative roles within the organization due to the company’s decision.

Google’s Hiroshi Lockheimer on the future of Android | The Telegraph

Directorship of the new division was assigned to Rick Osterloh, Senior Vice President of Devices and Services.

Rick Osterloh, Senior Vice President of Devices and Services | DerStandard

Sameer Samat, previously employed by Lockheimer, advanced to the position of president of Android Ecosystem.

Sameer Samat, Google takes aim at cheap phones, again, with Android Go – CNET

Burke announced in a post on X that he would continue to act as an advisor while he searches for a new endeavor.

“After fourteen years of overseeing Android engineering, I have realized it is time for a change.”

It is a remarkable voyage that contributes to the development of the world’s most extensive operating system and a significant number of Nexus and Pixel devices. The opportunity is one for which I will be eternally grateful.

He declared that he would persist in his role as an advisor while assessing the subsequent course of action in biology and artificial intelligence.

Dave Burke | X

Burke also sent a letter to his colleagues, subsequently published on LinkedIn.

In the letter, he expressed his intention to explore the potential of artificial intelligence in improving drug discovery.

“AI has the potential to play a pivotal role in accelerating drug discovery, with wide applicability, including in hard-to-treat pediatric cancers, a topic close to my heart. I’m working with Sundar to explore relevant roles at Alphabet,” he said.

Hillary Ondulohi

Hillary is a media creator with a background in mechanical engineering. He leverages his technical expertise to craft informative pieces on protechbro.com, making complex concepts accessible to a wider audience.

Disqus Comments Loading...

Recent Posts

Kevin Warsh- Treasury Secretary, Succeed Fed Chair Powell

Donald Trump is considering Kevin Warsh for Treasury Secretary and to succeed Jerome Powell as Fed Chair when his term…

6 minutes ago

Upbit Refunds Millions After Crypto Hack

Upbit refunded 8.5 billion won to 380 voice phishing victims, as authorities expose North Korea's involvement in previous hacks. Upbit,…

1 hour ago

Charles Schwab CEO Regrets Not Investing In Crypto

Rick Wurster, set to become CEO next year, stated he has no plans to buy crypto but aims to support…

2 hours ago

Federal Task Force Busts Cartel-Linked Crypto Laundering Ring

Nine individuals were charged with laundering U.S. drug proceeds into cryptocurrency for Mexican and Colombian cartels from 2020 to 2023.…

3 hours ago

Truemarkets Raises $4M in NFT Sale, Vitalik Buterin Purchases 400 NFTs

Truemarkets raised over $4M by selling 15,071 NFTs at $250 each. Vitalik Buterin bought 400 NFTs worth $107K in the…

4 hours ago

Apple Acknowledges Security Flaw Exposing Crypto Users—Here’s What to Do

Apple acknowledged on Monday that its devices were susceptible to an exploit that enabled the execution of remote malicious code…

4 hours ago